AKT1 and neoplasm: The observed downregulation of EPHX2 in tumor tissues correlates with aggressive tumor characteristics and unfavorable patient outcomes, underscoring the necessity for further exploration of its mechanistic pathways, particularly concerning the PI3K/AKT signaling pathway.